Camille D Samuels insider trades: Kythera Biopharmaceuticals (KYTH) stock buys and sales
Trades on the price chart
Daily close, with an arrow on each day they bought or sold
Companies
Where Camille reports to the SEC
and 2 more companies
Open-market buys and sales
11 trades reported on SEC Form 4, newest first
| Date | Stock | Type | Shares | Price | Value | Holding | Reported |
|---|---|---|---|---|---|---|---|
| Sep 1, 2015 | KYTH | ↓ Sell | 250 | $74.72 | $19K | Direct | Sep 2, 2015 (1d) |
| Aug 3, 2015 | KYTH | ↓ Sell | 250 | $74.51 | $19K | Direct | Aug 4, 2015 (1d) |
| Jul 1, 2015 | KYTH | ↓ Sell | 250 | $75.18 | $19K | Direct | Jul 2, 2015 (1d) |
| Jun 1, 2015 | KYTH | ↓ Sell | 250 | $49.97 | $12K | Direct | Jun 2, 2015 (1d) |
| May 1, 2015 | KYTH | ↓ Sell | 250 | $44.72 | $11K | Direct | May 4, 2015 (3d) |
| Apr 1, 2015 | KYTH | ↓ Sell | 250 | $48.93 | $12K | Direct | Apr 2, 2015 (1d) |
| Mar 2, 2015 | KYTH | ↓ Sell | 250 | $40.51 | $10K | Direct | Mar 3, 2015 (1d) |
| Feb 2, 2015 | KYTH | ↓ Sell | 250 | $37.31 | $9K | Direct | Feb 3, 2015 (1d) |
| Jan 16, 2015 | KYTH | ↓ Sell | 250 | $36.70 | $9K | Direct | Jan 21, 2015 (5d) |
| Sep 18, 2009 | HLCS | ↑ Buy | 242,931 | $2.57 | $625K | Versant Venture Capital II, L.P. | Sep 21, 2009 (3d) |
| May 30, 2007 | HLCS | ↑ Buy | 111,111 | $9.00 | $1000K | Versant Venture Capital II, L.P. | Jun 1, 2007 (2d) |
Each row is one filing's trades in one stock, summed. Shares and prices are as filed, before any later stock split.
About Camille D Samuels's insider trades
Camille D Samuels is a director at Kythera Biopharmaceuticals (KYTH). Since May 30, 2007, Camille has reported 2 open-market purchases worth $1.6M and 9 sales worth $121K on SEC Form 4. There have been no open-market trades in the last 12 months.
Their filings also include grants and awards (21 filings), conversions (4 filings), other transactions (3 filings), shares returned to the company (2 filings). These aren't open-market trades and aren't counted above.
How to read insider trades
Officers, directors and owners of more than 10% of a company must report trades in its stock on SEC Form 4, usually within two business days. Purchases with their own money are the stronger signal: insiders sell for many reasons (taxes, diversification, a house), but buy for one. See every KYTH insider trade, the latest insider trades across the market, or cluster buys, when several insiders buy the same stock within days.